Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
To verify whether the transpulmonary pressure-guided mechanical ventilation strategy can reduce right ventricular involvement, especially the incidence of acute cor pulmonale (ACP), in patients with moderate to severe ARDS induced by pneumonia compared with the currently widely used right ventricular protective mechanical ventilation strategy.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Ciężkie zapalenie płuc wymagające sztucznego oddychania
- •Niski poziom tlenu we krwi
- •Wymaga sztucznego oddychania (respiratora)
- •Podpisana zgoda na uczestnictwo w badaniu
✗ Disqualifies
- •Sztuczne oddychanie przez więcej niż 48 godzin
- •Historia wysokiego ciśnienia w naczyniach płucnych
- •Poważne zaburzenia rytmu serca
- •Wszczepiony transplant płuca
- •Aktywny przeciek powietrza w płucach
- •Ciężka niewydolność wątroby
- •Uczestnictwo w innym badaniu nad zapaleniem płuc w ostatnich 30 dni
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 12, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Beijing Chao-Yang Hospital
Beijing, China
Trial contact
Xiao Tang, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/13/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.